Venture Life Group PLC
(“Venture Life” or the “Company”)
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it was notified on 4 April 2018 that Jerry Randall, Chief Executive Officer of the Company, has transferred at total of 99,020 ordinary shares of 0.3p each in the Company at 41p per share into Individual Savings Accounts held by him and his wife. Following the transaction, Jerry Randall's beneficial interest is unchanged at 3,931,129 ordinary shares representing 10.7 per cent. of the Company's issued share capital.
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive Officer
James Hunter, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker) +44 (0) 20 7886 2500
Freddy Crossley/Peter Steel/Duncan Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Ltd (Joint Broker) +44 (0) 20 3621 4120
James Pope/Ben Turner
Walbrook PR email@example.com or +44 (0) 20 7933 8780
Paul McManus/Anna Dunphy +44 (0) 7980 541 893 / +44 (0) 7876 741 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group’s product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women’s intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group’s international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.